Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HF 4140Sesión 2025-2026

Minnesota Community Pharmacy Patient Access and Fair Reimbursement Act established, and rulemaking required.

Introduction 9 de marzo de 2026

El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.

Skip to main content Skip to footer Minnesota Legislature Advanced Search Search Legislature Search Menu
  • House
  • Minnesota House of Representatives House Members and Staff House Members Leadership Staff Employment Who Represents Me? Committees Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Minutes Committee Deadlines Offices Chief Clerk Fiscal Analysis House Research Public Information Sergeant-at-Arms Caucuses - DFL/GOP Other Information House Journal House Rules Joint Rules Educational Programs Pronunciation Guide Address Spreadsheet
  • Senate
  • Minnesota Senate Senators and Staff Senators Leadership Staff Employment Who Represents Me? Committees Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Committee Deadlines Offices Secretary of the Senate Senate Counsel, Research & Fiscal Analysis Caucuses - DFL/GOP Other Information Senate Journal Senate Rules Joint Rules Educational Programs Address Labels Subscriptions
  • Joint
  • Joint Department, Offices, and Commissions Joint Legislative Offices Legislative Budget Office Legislative Coordinating Commission (LCC) Legislative Reference Library Office of the Legislative Auditor Office of the Revisor of Statutes Commissions Legislative-Citizen Commission on MN Resources Legislative Commission on Pensions & Retirement Lessard-Sams Outdoor Heritage Council More... More Information Joint Offices Directory Joint Offices Staff Accessibility Legacy Amendment
  • Schedules
  • Schedules, Calendars, and Legislative Business House House Schedules Order of Business Calendar for the Day Supplemental Calendar for the Day Fiscal Calendar Senate Senate Schedules Order of Business Senate Calendar General Orders of the Day Joint Combined Upcoming Meetings Broadcast TV Schedule Committee Deadlines
  • Committees
  • Legislative Committees House Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Minutes Senate Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Joint Joint Committees & Task Forces Committee Deadlines Bills In Conference Committee Side by Side Comparisons
  • Bills
  • Bills House Bill Search & Status (House) Bill Introductions Bill Summaries Act Summaries Fiscal Tracking Sheets Senate Bill Search & Status (Senate) Bill Introductions Bill Summaries Act Summaries Fiscal Tracking Sheets Joint Bill Search & Status MyBills Side by Side Comparisons Bills In Conference Committee Vetoes Current Session Laws
  • Law
  • Statutes, Laws, and Rules Statutes Keyword Search Current Statutes Statutes by Topic (Index) Statutes Archive Session Laws Keyword Search Current Session Laws Session Laws by Topic (Index) Session Laws Archive Session Laws Changed (Table 1) Statutes Changed (Table 2) Administrative Rules Keyword Search Current Rules Rules by Topic (Index) Rules Archive Minnesota Rule Status State Register Other Legal Materials Minnesota Constitution State Constitutional Amendments Court Rules
  • Multimedia
  • Multimedia - Audio, Video, Broadcast TV, News, & Photos House Live Video Audio Webcast Schedule Audio & Video Archives Session Daily Photos Senate Live Video Audio Webcast Schedule Audio & Video Archives Senate Media Services Photos Joint Combined Media Page Legislative Media Archive Broadcast TV Schedule Commission Audio/Video
  • Publications
  • Legislative Research, Reports & Information Office Research & Reports House Fiscal Analysis House Research Senate Counsel Publications Legislative Auditor Revisor Publications Legislative Reference Library News House Session Daily Senate Media Services Senate Information Legislators Roster Member Guide Legislative History Legislative History Guide Legislators Past & Present House Journal Senate Journal Legislative Time Capsule Vetoes Notable Documents Fiscal Review Minnesota Issues Guides New Laws Books & reports
Search Legislature Search Office of the Revisor of Statutes

Office of the Revisor of Statutes

Revisor Menu
  • Retrieve by number Document type Statutes Laws Rules Bills GO
  • Statutes
  • Laws
  • Rules
  • Court Rules
  • Constitution
  • Revisor's Office Revisor Intranet Attorney Drafting Areas Staff Directory Office Duties Publications Educational Seminars Employment Openings Order Publications
  • Search Law by Keyword
  • Bills
  • 94th Legislature (2025 - 2026)
  • HF4140
  • Introduction

HF 4140

Introduction - 94th Legislature (2025 - 2026)

Posted on 03/09/2026 03:40 p.m.

KEY: stricken = removed, old language. underscored = added, new language. Version List HF4140 Authors and Status PDF Rtf

Bill Text Versions

Engrossments
Introduction PDF Posted on 03/09/2026
Jump to page/line # Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27 4.28 4.29 4.30 4.31 4.32 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10 5.11 5.12 5.13 5.14 5.15
5.16

A bill for an act
relating to health; establishing the Minnesota Community Pharmacy Patient Access
and Fair Reimbursement Act; requiring rulemaking; proposing coding for new
law in Minnesota Statutes, chapter 62J.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [62J.901] MINNESOTA COMMUNITY PHARMACY PATIENT ACCESS
AND FAIR REIMBURSEMENT ACT.
new text end

new text begin Subdivision 1. new text end

new text begin Title. new text end

new text begin This section shall be known as the "Minnesota Community
Pharmacy Patient Access and Fair Reimbursement Act."
new text end

new text begin Subd. 2. new text end

new text begin Scope. new text end

new text begin This section is intended to protect patients' access to community
pharmacies by ensuring sustainable reimbursement rates for community pharmacies and to
prevent unfair reimbursement practices that cause pharmacy closures, thereby safeguarding
patient access to essential pharmaceutical care and maintaining a strong community health
infrastructure across the state. This section regulates pharmacy benefit manager conduct
and reimbursement practices and does not alter health plan benefit design or federal program
requirements.
new text end

new text begin Subd. 3. new text end

new text begin Definitions. new text end

new text begin (a) For purposes of this section, the following terms have the
meanings given.
new text end

new text begin (b) "Community pharmacy" means an outpatient retail pharmacy licensed under chapter
151 that is not owned, operated, managed, or controlled, either directly or indirectly, through
an affiliate or subsidiary by a:
new text end

new text begin (1) pharmacy benefit manager licensed under chapter 62W;
new text end

new text begin (2) health carrier, as defined in section 62A.011, subdivision 2;
new text end

new text begin (3) government entity;
new text end

new text begin (4) mail-order pharmacy; or
new text end

new text begin (5) specialty pharmacy.
new text end

new text begin (c) "National Average Drug Acquisition Cost" or "NADAC" means the publicly available,
federally established benchmark reflecting the average acquisition cost of outpatient
prescription drugs purchased by retail community pharmacies, as determined by the Centers
for Medicare and Medicaid Services.
new text end

new text begin (d) "Pharmacy benefit manager" or "PBM" has the meaning given in section 62W.02,
subdivision 15.
new text end

new text begin (e) "Pharmacy reimbursement ceiling" means the maximum reimbursement rate for
prescription drugs dispensed by a pharmacy established under subdivision 4.
new text end

new text begin (f) "Professional dispensing fee" means the fee paid to a pharmacy for the cost of
dispensing a medication, excluding the cost of the drug itself. The fee is intended to cover
the professional services provided by the pharmacy dispensing the medication, in accordance
with section 256B.0625, subdivision 13e.
new text end

new text begin (g) "Wholesale acquisition cost" or "WAC" means the manufacturer's list price for a
prescription drug to wholesalers or direct purchasers in the United States, not including any
discounts, rebates, or other price concessions.
new text end

new text begin Subd. 4. new text end

new text begin Fair pharmacy reimbursement. new text end

new text begin (a) Except as provided in paragraph (c), this
subdivision applies to prescription drugs dispensed by a community pharmacy, as defined
in subdivision 3, and to claims adjudicated by a PBM under a health plan or pharmacy
benefit plan.
new text end

new text begin (b) To improve patient access to pharmacy services and support the financial viability
of community pharmacies, for any prescription drug dispensed by a community pharmacy
and for any claim adjudicated by a PBM to which this subdivision applies, the total
reimbursement to the community pharmacy must be equal to:
new text end

new text begin (1) the NADAC for the drug on the day of claim adjudication or, if the NADAC is
unavailable, the WAC for that drug on the day of claim adjudication, plus an additional
amount equal to four percent of the calculated total ingredient cost as derived from the
applicable NADAC or WAC amount, or $50, whichever is less; and
new text end

new text begin (2) a professional dispensing fee as specified in section 256B.0625, subdivision 13e,
which must be equal to the professional dispensing fee paid by the state under the medical
assistance program and adjusted biennially based on an independent cost-of-dispensing
survey reflecting inflation, labor costs, and operational expenses.
new text end

new text begin (c) The reimbursement standard established in this subdivision constitutes both the
minimum and maximum reimbursement amount for purposes of this section and may not
be altered by contract, network design, or other reimbursement methodology.
new text end

new text begin Subd. 5. new text end

new text begin Scope of application; covered entities; exclusions. new text end

new text begin (a) Nothing in this section
requires reimbursement at or above NADAC or WAC for drugs purchased under the federal
340B Drug Pricing Program. Reimbursement for drugs purchased under the 340B program
must comply with applicable state and federal law.
new text end

new text begin (b) This section does not apply to claims paid under Medicare or Medicaid, including
claims paid under Medicare Part B, Medicare Part D, and Medicaid fee-for-service or
managed care, or under any other state or federal program for which reimbursement is
established by statute, regulation, state plan, contract approved by a federal agency, or
federal waiver.
new text end

new text begin (c) This section regulates the reimbursement practices of pharmacy benefit managers
licensed under chapter 62W with respect to claims paid under commercial health plans and
pharmacy benefit plans subject to state regulation.
new text end

new text begin Subd. 6. new text end

new text begin Prohibition on below-cost and postclaim manipulation. new text end

new text begin (a) A PBM must
not reimburse a community pharmacy in an amount below the reimbursement standard
established in this section.
new text end

new text begin (b) A PBM must not impose any fee, adjustment, recoupment, reconciliation payment,
performance metric, direct or indirect remuneration fee, or other mechanism that results in
a community pharmacy receiving less than the total reimbursement required under this
section.
new text end

new text begin Subd. 7. new text end

new text begin Ban on spread pricing. new text end

new text begin PBMs are prohibited from engaging in spread pricing
in commercial and state-regulated plans. A PBM may not retain any portion of payments
made by a health plan, insurer, government program, or other payer beyond the amount
paid to the dispensing pharmacy, less enrollee cost sharing. PBMs must remit to the
dispensing pharmacy 100 percent of payments received, less patient cost-sharing.
new text end

new text begin Subd. 8. new text end

new text begin Prohibition of retroactive claim denials. new text end

new text begin PBMs must not retroactively deny
or reduce claim reimbursement except in cases of fraud, billing errors, or documented
overpayment verified through an audit.
new text end

new text begin Subd. 9. new text end

new text begin Prohibition on patient steering. new text end

new text begin PBMs must not require, coerce, steer, or
financially penalize an enrollee to use a PBM-owned, affiliated, or mail-order pharmacy.
A PBM must not impose higher cost-sharing, reduced benefits, or other financial or
administrative disadvantages on an enrollee who chooses to obtain prescription drugs from
a community pharmacy.
new text end

new text begin Subd. 10. new text end

new text begin Enforcement and penalties. new text end

new text begin (a) The Department of Commerce has exclusive
authority to administer and enforce this section.
new text end

new text begin (b) A community pharmacy, health carrier, plan sponsor, or enrollee may file a complaint
with the commissioner alleging a violation of this section. The commissioner shall investigate
alleged violations and may require the submission of claims data, pricing files, contracts,
and any other records necessary to determine compliance.
new text end

new text begin (c) To ensure compliance with this section, the commissioner may:
new text end

new text begin (1) conduct investigations and compel the production of unredacted records, pricing
agreements, claims data, contracts, and internal communications relevant to reimbursement
practices;
new text end

new text begin (2) order corrective action including restitution, cease-and-desist orders, and prospective
pricing adjustments to remedy and prevent violations;
new text end

new text begin (3) require annual compliance certification from PBMs attesting to full compliance with
this section. A false certification is subject to civil penalties and potential suspension of
licensure; and
new text end

new text begin (4) publish an annual compliance report summarizing:
new text end

new text begin (i) the number of violations identified;
new text end

new text begin (ii) the amount of fines and restitution collected; and
new text end

new text begin (iii) the impact on community pharmacy access and closures.
new text end

new text begin (d) A PBM found to be reimbursing below the reimbursement standard established in
subdivision 4 is subject to a civil penalty of $5,000 per violation per claim. Repeat violations
are subject to escalating penalties of up to $20,000 per claim, not to exceed $2,000,000 per
enforcement action. The Department of Commerce may impose additional sanctions,
including suspension or revocation of a PBM's license to operate in the state.
new text end

new text begin (e) If the commissioner determines that a PBM has violated this section, the commissioner
may:
new text end

new text begin (1) order full restitution to the affected pharmacy, including interest and reasonable costs
incurred in the administrative proceeding; and
new text end

new text begin (2) impose any additional sanctions authorized under this section.
new text end

new text begin (f) A pharmacist or other individual who, in good faith, reports noncompliance, fraudulent
reimbursement practices, or retaliatory conduct by a PBM is protected from retaliation. The
commissioner shall establish a secure and confidential process for receiving reports. Verified
violations may result in additional penalties or corrective action.
new text end

new text begin (g) A final order of the commissioner is subject to judicial review under chapter 14.
new text end

new text begin Subd. 11. new text end

new text begin Rulemaking. new text end

new text begin The commissioner of commerce shall adopt necessary rules to
implement this section.
new text end

new text begin Subd. 12. new text end

new text begin Severability. new text end

new text begin If any provision of this section or its application to any person
or circumstance is held invalid, the invalidity does not affect other provisions or applications
of the section that can be given effect without the invalid provision or application.
new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2026.
new text end

About the Legislature
  • Historical Information
  • Employment/Internships
  • Visiting the Capitol
  • Accessibility
  • Frequently Asked Questions
Contact Your Legislator
  • Who Represents Me?
  • House Members
  • Senators
General Contact
  • Contact a legislative librarian:
  • (651) 296-8338 or Email
  • Phone Numbers
  • Submit website comments
Get Connected
  • House News
  • Senate News
  • MyBills
  • Email Updates & RSS Feeds
Minnesota Office of the Revisor of Statutes, Centennial Office Building, 3rd Floor, 658 Cedar Street, St. Paul, MN 55155

Texto oficial de la Legislatura de Minnesota. El formato se adaptó para leerlo en Ratifi.